naproxen
naproxen is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including naproxen. Available dosage form: tablet.
Drug Details
- Generic Name
- naproxen
- Brand Names
- naproxen
- Application Number
- ANDA091305
- Sponsor
- Cipla USA Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- NAPROXEN
Indications and Usage
1 INDICATIONS & USAGE Naproxen delayed-release tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis Polyarticular Juvenile Idiopathic Arthritis Naproxen delayed-release tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis